BIOADAPTIVES, INC.
For the period ended Dec 31, 2024. Filed Apr 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 15, 2025
BDPTStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements, Auditor’s Notes and Supplemental Data
Item 8 - Financial Statements and Supplementary Data
BIOADAPTIVES, INC
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED****DECEMBER 31, 2024, AND 2023
| TABLE OF CONTENT | PAGE | |
|---|---|---|
| Report of Independent Registered Public Accounting Firm | F-2 | |
| Consolidated Balance Sheet | F-3 | |
| Consolidated Statements of Operations | F-4 | |
| Consolidated Statements of Stockholders’ Deficit | F-5 | |
| Consolidated Statements of Cash Flows | F-6 | |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.